Schmut Otto, Horwath-Winter Jutta, Zenker Andrea, Trummer Gabriele
University Eye Hospital, Auenbruggerplatz 4, 8036 Graz, Austria.
Graefes Arch Clin Exp Ophthalmol. 2002 Nov;240(11):900-5. doi: 10.1007/s00417-002-0537-0. Epub 2002 Oct 2.
Qualitative and quantitative determination of tear fluid components is of increasing interest in ophthalmology. Until now, for diagnosis and course control of some diseases of the anterior parts of the eye, different methods for tear fluid protein analysis are available. Results can be obtained by polyacrylamide gel electrophoresis (PAGE), immunochemistry, and high-performance liquid chromatography (HPLC). A new method for protein separation, identification and semi-quantitative determination on a chip-based micro-fluidic technique is used for the first time to investigate tear fluids.
Normal human reflex tears were obtained by stimulation with China mint oil and collected using glass capillary tubes. A lab-on-a-chip technology (developed by Agilent Technologies, Waldbronn, Germany, in co-operation with Caliper Technologies, Mountain View, California, USA) was used for separation and semi-quantitative determination of tear proteins. Tear fluid was separated on the Agilent 2100 Bioanalyzer in combination with the Protein 200 LabChip kit and the dedicated protein assay software. Time and temperature of the incubation with sample buffer were varied, and the influence of these parameters on protein separation profiles was studied. Tear proteins were also analysed by PAGE, and the results obtained by both methods were compared.
The different proteins of tear fluid can be separated by the Agilent 2100 Bioanalyzer method in very short time. By this method, the molecular weight as well as the concentration of proteins can be determined. Data are automatically stored in digital format and can be retrieved and shared. Results of this technology were comparable with the protein pattern obtained by PAGE. It was confirmed by both methods that, depending on incubation time of tear fluid with sample buffer and on temperature, different protein pattern can be obtained from the tears of one specimen.
Tear proteins - in contrast to serum or aqueous humour proteins - are very sensitive to changes in sample buffer temperature as well as incubation time with buffer. To obtain comparable results for tear fluid proteins, the sample buffer applied and the incubation time and temperature must be observed carefully. This can be demonstrated by both the new Agilent 2100 Bioanalyzer method and PAGE. These results are of importance when comparing tear fluid protein pattern for the diagnosis and course control of dry-eye syndrome and of other diseases of the anterior part of the eye.
泪液成分的定性和定量测定在眼科领域的关注度日益增加。到目前为止,对于眼前部某些疾病的诊断和病程控制,有多种泪液蛋白质分析方法可供使用。可通过聚丙烯酰胺凝胶电泳(PAGE)、免疫化学和高效液相色谱(HPLC)获得结果。一种基于芯片的微流控技术用于蛋白质分离、鉴定和半定量测定的新方法首次被用于研究泪液。
用薄荷油刺激获取正常人的反射性泪液,并用玻璃毛细管收集。采用一种芯片实验室技术(由德国瓦尔布隆的安捷伦科技公司与美国加利福尼亚山景城的卡利珀科技公司合作开发)对泪液蛋白质进行分离和半定量测定。泪液在安捷伦2100生物分析仪上结合Protein 200 LabChip试剂盒和专用蛋白质分析软件进行分离。改变样品缓冲液孵育的时间和温度,并研究这些参数对蛋白质分离图谱的影响。泪液蛋白质也通过PAGE进行分析,并比较两种方法获得的结果。
安捷伦2100生物分析仪方法能在极短时间内分离泪液中的不同蛋白质。通过该方法,可以确定蛋白质的分子量和浓度。数据以数字格式自动存储,可检索和共享。该技术的结果与PAGE获得的蛋白质图谱相当。两种方法均证实,根据泪液与样品缓冲液的孵育时间和温度不同,同一个体的泪液可获得不同的蛋白质图谱。
与血清或房水蛋白质不同,泪液蛋白质对样品缓冲液温度以及与缓冲液的孵育时间变化非常敏感。为获得可比的泪液蛋白质结果,必须仔细观察所用的样品缓冲液、孵育时间和温度。新型安捷伦2100生物分析仪方法和PAGE均可证明这一点。在比较泪液蛋白质图谱以诊断和控制干眼综合征及眼前部其他疾病时,这些结果具有重要意义。